GPT and metabolic dysfunction-associated steatotic liver disease: Aminotransaminase (ALT) is the most commonly used biomarker of chronic liver disease to evaluate the function of the liver.57 However, in NAFLD, the ALT level alone provides limited information and is poorly predictive because of its low specificity.